Dragon and Tiger List | YKYY (688658) fell by 15.77%, with the top 5 buyers purchasing a total of 116 million yuan, and the top 5 sellers selling a total of 163 million yuan. Reason for being listed: The closing price drop of the top five securities reached 15% with price fluctuation limits同壁财经·Jun 5 at 06:55 AM688658+2.16%
Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suitWallstreetcn·Mar 16 at 09:28 PM688336+3.61%688513+0.81%
Fangzhou, Youcare Partner To Advance AI In Chronic Disease Carerttnews·Feb 28 at 10:54 PM06086+5.88%510660+0.86%
Fangzhou teams up with Youcare Pharma to improve chronic care services using AI, boosting digital transformation.Unusual Whales·Feb 28 at 01:22 AM159929+0.68%512010+0.27%
Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI-Driven Chronic Care ServicesGlobeNewswire·Feb 28 at 01:12 AM516610+1.66%512010+0.27%
YKYY: Planning to issue H shares and list on the Hong Kong Stock Exchange LimitedWallstreetcn·Dec 5, 2025 at 03:20 AM688658+2.16%
Guotai Haitong: siRNA drug technology upgrades drive breakthroughs in common disease treatment, Chinese companies can achieve differentiated advantages in multiple areasZhitong·Oct 9, 2025 at 09:20 PM600276-1.04%601211-3.52%
Shenwan Hongyuan: Small nucleic acid drugs enter a rapid development stage, domestic companies accelerate to seize the blue oceanZhitong·Sep 26, 2025 at 01:56 AM01276-0.52%688658+2.16%
Innovative drug concept stocks surged and then fell back, with Mengke Pharmaceutical dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with the largest declinesZhitong·Sep 25, 2025 at 12:43 AM688166+3.49%301096+5.17%
YKYY's subsidiary YKYY013 injection has received FDA clinical trial approvalZhitong·Sep 22, 2025 at 04:20 AM688658+2.16%
YKYY: Independent director Cheng Hua has applied for resignation due to personal reasonsZhitong·Sep 11, 2025 at 04:20 AM688658+2.16%
Innovative drug concept stocks are repeatedly active, Chimin hits the daily limitZhitong·Sep 3, 2025 at 08:41 PM688356+0.43%688658+2.16%
Innovative drug concept stocks rose at the beginning of the trading session, YKYY increased by over 10%Zhitong·Sep 2, 2025 at 08:41 PM300255+3.53%300363+3.81%
The cell immunotherapy sector is partially active, with Sanyuan Gene rising over 12%Zhitong·Jul 28, 2025 at 09:06 PM688621+0.70%603127+3.72%
Dongfang Securities: The potential of small nucleic acid drugs for treatment is emerging, pay attention to potential BD opportunitiesZhitong·Jul 28, 2025 at 04:08 AM01177-0.59%688180+2.15%
